Transmissible spongiform encephalopathies are closely linked to the accumulation of a pathological isoform of a host-encoded prion protein (PrP C ), designated PrP Sc . In an attempt to generate monoand polyclonal antibodies to ruminant PrP, 32 mice were vaccinated with peptide vaccines which were synthesized according to the amino acid sequence of ovine PrP. By this approach five PrP-reactive polyclonal antisera directed against four different domains of the protein were stimulated. Splenocytes of mice which had developed PrP-reactive antibodies were used for the generation of monoclonal antibodies (MAbs). Obtained PrP-specific
Introduction
Scrapie in sheep and goats is an endemically maintained transmissible spongiform encephalopathy (TSE) in many countries. In the last 10 years a vast epidemic of bovine spongiform encephalopathy (BSE) has developed in the UK with to date more than 165 000 cows succumbed to the disease (Anderson et al., 1996) . Since 1996 a new variant of Creutzfeldt-Jakob disease has been observed predominantly in the UK which seems to be caused by transmission of BSE agent to humans (Bruce et al., 1997 ; Hill et al., 1997) . Therefore many efforts are undertaken to develop novel tests for the preclinical and post mortem diagnosis of these diseases.
A substantial amount of data has accumulated indicating that TSEs may not be transmitted by conventional viruses, but by the pathological isoform of a cellular protein, designated PrP Sc (Prusiner, 1982 (Prusiner, , 1991 . PrP Sc is a conformational variant of a host-encoded cellular protein designated PrP C (Oesch et al., 1985) . PrP C is a sialoglycoprotein with a molecular mass of MAbs were directed to three different domains of ruminant PrP which differed from the three previously described major MAb binding sites in rodent PrP. MAbs exhibited reactivity with non-denatured ruminant PrP C in ELISA and immunoprecipitation and with denatured ovine and bovine PrP Sc in immunoblot. Cross-reactivity was observed with PrP C of nine other mammalian species and with pathological PrP preferably of ruminants and weakly with that of hamster and mouse. The generated MAbs will be useful tools for the development of diagnostic tests for BSE and scrapie as well as for pathogenesis studies of these diseases.
33-35 kDa and is attached to the cell membrane of mammalian cells by a glycosyl phosphatidyl inositol anchor. According to the prion theory, PrP C converts into PrP Sc autocatalytically (Prusiner, 1982) . Conversion experiments in vitro in scrapieinfected tissue culture cells and in transgenic mice revealed that the efficiency of this process is improved if host PrP C and exogenous PrP Sc display similar amino acid (aa) sequences (Scott et al., 1993 ; Kocisko et al., 1995) . PrP Sc exhibits a high tendency to aggregate into so-called prion rods or scrapieassociated fibrils and is characterized by a partial resistance to proteinase K digestion (Prusiner et al., 1983) .
Both PrP isoforms of a given species have been shown to be identical in their primary structure, but physical measurements have demonstrated a dramatic conformational difference between them. In Fourier transform circular dichroism spectrometry PrP Sc has been shown to have an increased β-sheet content (Pan et al., 1993) . The different behaviour of the two conformationals of PrP towards chemical influences like the partial resistance of PrP Sc to proteinase K or their solubility differences in non-denaturing detergents are perhaps linked to those distinct conformational states.
Cellular PrP is expressed in all mammalian species investigated to date, with 90 % homology in the amino acid sequence. Therefore, the generation of antibodies to PrP is generally hampered by immunotolerance effects. Accordingly, anti- bodies are stimulated primarily to PrP epitopes with differing amino acid sequences in the donor and the vaccinated species. However, the number of such epitopes is very limited.
Most MAbs reported to date were raised to hamster PrP Sc . These MAbs exhibit little or no cross-reactivity with murine PrP and no antibody is yet available which differentiates between the two isoforms of PrP Kascak et al., 1987) . Rogers et al. (1991) found three distinct epitopes of hamster PrP recognized by 18 different MAbs. The first epitope (3F4 epitope) includes methionines at positions 109 and 112 (corresponding to positions 112 and 115 in the ovine PrP sequence used in Fig. 1 ), while the two other epitopes enclose a methionine at position 139 and one of the asparagines at positions 155 and 170 (numbering according to hamster PrP).
The generation of MAbs to human PrP by using DNA immunization of PrP! /! mice has been reported recently (Krasemann et al., 1996) . These MAbs bind either to an epitope upstream of or within the repetitive region (according to aa 40-97 of the ovine sequence), to a region located aminoterminally from the 3F4 epitope or to another region according to aa 145-163 of the ovine sequence (Fig. 1) . A different approach was chosen by Williamson et al. (1996) who retrieved mouse-PrP-specific recombinant antibodies from a phage display library of splenocytes.
However, MAbs raised to amino acid sequences of ovine or bovine PrP have not been reported in the literature. Such antibodies should be superior tools for the immunodetection of ovine and bovine PrP Sc for diagnostic purposes as well as for pathogenesis studies on scrapie and BSE.
Methods
Materials. Brain tissue of healthy Merino sheep, Alpine goats, Holstein Friesian cows and Large White pigs were collected at the local abattoir. Brain tissue of Syrian hamsters, C57BL\6 mice, Wistar rats and guinea-pigs were derived from animals bred in our institute. Brain tissue from two German shepherd dogs and three cats (European short-hair cats) was supplied by K. Frese, University of Giessen, Germany. Four mink brains were purchased from A. Grosser, Bielefeld, Germany. Human brain material was contributed by R. Meyermann, University of Tu$ bingen, Germany. Scrapie and BSE brain tissues originated from diseased sheep, goat and cattle field cases.
Murine PrP Sc was derived from mice infected with scrapie strain Chandler ; hamster PrP Sc was from hamsters infected with the scrapie strain 263 K.
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Immunization with synthetic peptides. Sixteen synthetic peptides spanning the complete amino acid sequence of ovine PrP were synthesized using an automated peptide synthesizer (Milligen 9050) and FMOC chemistry. The respective peptide sequences are shown in Fig. 1 . Before application peptides were coupled to keyhole limpet haemocyanin in an overnight procedure using glutaraldehyde. For immunizations, coupled peptides were emulsified with ABM-ZK adjuvant (Linaris, Bettingen, Germany) and administered intraperitoneally. Two mice per peptide antigen were vaccinated respectively. The initial injection and first boost injection contained 200 µg peptide, all other injections contained 100 µg. Boost injections were given at least three times in 4-week intervals. Blood samples were taken from the tail 10 days after the last injection. OD &! titres of the sera were determined by ELISA (see below).
Purification of cellular PrP. PrP C from brain tissue of all species was extracted and purified using immobilized metal affinity chromatography (IMAC) as described by Pan et al. (1992) . Briefly, brain tissue was homogenized with an electric homogenizer in PBS containing 0n32 M sucrose, 1 mM PMSF, 0n1 mg\ml N-tosyl--phenylalanine-chloromethyl ketone (TPCK). Cell debris was pelleted at 300 g for 30 min, and the supernatant was supplemented with polyethylene glycol (PEG 8000 ; Sigma) (4 % w\v). Microsomes and membrane particles were precipitated for 15 min at 4 mC, pelleted at 14 000 g for 10 min, collected and resolubilized in PBS containing 6 % Zwittergent (% in reference to the brain mass used), 1 mM PMSF and 0n1 mg\ml TPCK. Eventually the solution was cleared of remaining microsomal debris at 100 000 g for 1 h at 4 mC and filtered through a 0n22 µm pore membrane. Detergent-soluble proteins were applied to Cu ++ -charged chelating Sepharose equilibrated with PBS containing 0n2 % Zwittergent and 0n5 M NaCl. The bound proteins were eventually eluted by PBS\Zwittergent supplemented with 50 mM EDTA. The eluate was dialysed against 0n05 M Tris-HCl buffer (pH 8n0) for 18 h, lyophilized and resolubilized in 1\33rd of the starter volume.
To increase antigenic purity of ovine PrP C , IMAC eluate was further purified on a protein A column charged with and covalently linked to polyclonal rabbit antibodies, which were raised to the hexapeptide region (positions 37-53 ; Fig. 1 ) of ovine PrP. Bound PrP C was eluted with a buffer containing 3 M magnesium chloride and 25 % ethylene glycol. Such immunopurified PrP C was used for ELISA studies. One hundred grams of sheep brain yielded 100 µg IMAC-purified PrP C or an amount of immunoaffinity-purified PrP C sufficient to coat 50 wells of a 96-well ELISA plate.
Purification of ovine, bovine, caprine, hamster and murine PrP
Sc . Ovine, bovine, caprine, hamster and murine PrP Sc was purified using a modified protocol as described by Hope et al. (1988) . In short, infectious brain tissue (2 g) was homogenized in 5 ml brain lysis buffer [0n01 M sodium phosphate containing 10 % N-lauroylsarcosine, 3 mM PMSF and 3 mM N-ethylmaleimide (NEM)]. Firstly, cell detritus was pelleted at 20 000 g for 30 min and in a further centrifugation step fibrils were pelleted at 156 000 g for 2n25 h. Pellets were resolubilized in 3 ml 16 mM Tris buffer (pH 7n4) and incubated at 37 mC. After 30 min, 6 ml potassium iodide buffer (15 % potassium iodide, 60 mM sodium thiosulfate 5-hydrochloride, 10 mM Tris buffer pH 7n4) was added and probes incubated for another 30 min at 37 mC. Probes were subsequently treated with proteinase K (10 µg\ml) for 1 h at 37 mC. After adding 4n5 ml potassium iodide buffer (10 %) to each sample fibrils were pelleted at 220 000 g for 1 h and dried.
SDS-PAGE and immunoblotting.
For electrophoretical separation on a 13 % polyacrylamide gel, probes were resolubilized with 0n5i sample buffer (2 % SDS, 10 % glycerol, 0n001 % bromphenol blue in 60 mM Tris buffer pH 8n5), denatured for 5 min at 95 mC, and finally electrotransferred to nitrocellulose. Surplus binding sites were blocked by incubating the membranes in 5 % non-fat dry milk solubilized in PBS supplemented with 0n1 % Tween 20 and 5 % foetal calf serum for 30 min at room temperature. Membranes were then incubated with either polyclonal mouse serum at a dilution of 1 : 150 in blocking solution or undiluted hybridoma supernatant for 2 h at room temperature, washed excessively in PBS containing 0n1 % Tween 20 and thereafter incubated with alkaline phosphatase-conjugated caprine antibody to murine IgG (diluted 1 : 3000 in blocking solution) (Dianova). After further washings antibody binding was visualized by conversion of NBT\BCIP (Fluka Chemie) into chromogen.
Immunoprecipitation. For detection of PrP C by immunoprecipitation brain material of non-infected sheep, goat, cattle, man, dog, hamster and mouse were used. Brain tissue was homogenized in 9 vols 0n34 M sucrose, 0n5 % NP40 and 0n5 % sodium deoxycholate (DOC) and centrifuged at 20 000 g for 10 min. PrP C -containing supernatants were used for precipitation. Before adding MAbs, brain homogenates were diluted at a ratio of 1 : 10 in lysis buffer (0n01 M Tris buffer, 0n1 M sodium chloride, 0n01 M EDTA, 0n5 % NP40, 0n5 % DOC pH 7n8). After precipitation for 1 h protein A-Sepharose was added for 30 min and PrPimmune complexes were subsequently pelleted. Beads were thoroughly washed in lysis buffer, mixed with sample buffer (see above), sonicated for 30 s, heated for 5 min at 95 mC and briefly centrifuged at 10 000 g. Supernatants were used for electrophoretical separation and immunoblotting was performed as described above. Protein bands were visualized by chemiluminescence using ECL substrate (Amersham).
ELISA. Synthetic peptides (200 ng per well)
, IMAC PrP C (1 : 80 dilution) or immunoaffinity-purified PrP C (purified yield equivalent to 1 g starting tissue per well) were solubilized in 0n1 M sodium carbonate buffer (pH 9n6), and coated overnight onto microtitre plates (Nunc Maxi Sorb, Nunc) at room temperature. Non-specific binding sites were blocked with the blocking solution as used for immunoblot for 30 min at room temperature. Polyclonal antiserum dilutions (1 : 200 in blocking buffer) or undiluted hybridoma supernatants were applied for 2 h at 37 mC, wells were excessively rinsed with PBS-Tween and further incubated with peroxidase-linked caprine antibodies (diluted 1 : 3000 in blocking solution) specific for mouse IgG and IgM for another hour at 37 mC. After excessive washings antibody binding was visualized using ortho-phenyldiamine substrate. Optical density was measured at 492 nm. OD &! anti-peptide antibody titres of polyclonal sera were determined by finding the antibody dilution giving 50 % of the optical density of the maximal colour reaction.
Generation and characterization of MAbs. All mice that had developed PrP-reactive anti-peptide sera in immunoblot were selected for hybridoma production. Final boosts were administered intraperitoneally 72 h before fusion (100 µg peptide in 0n5 ml sterile PBS). Spleen lymphocytes were fused to the myeloma cell line SP2\0 (Shulmann et al., 1978) by PEG. After 10 days hybridomas were tested by ELISA for the production of peptide-specific antibodies. Selected hybridomas were cloned by limiting dilution and antibodies were further characterized for their reactivity with different preparations of PrP C (a) by ELISA using non-denatured IMAC PrP C and immunoaffinity-purified PrP C , (b) by immunoprecipitation using crude brain homogenates, and (c) in immunoblot with denatured antigen (IMAC PrP C and purified PrP Sc ). In order to demonstrate peptide-and PrP-specific reactions in ELISA and immunoblot, MAbs were preincubated with the corresponding synthetic peptides (200 µg\ml).
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Results
Generation and characterization of polyclonal antipeptide sera in mice
Thirty-two mice were vaccinated with 16 synthetic peptides, which span almost the complete amino acid sequence of ovine PrP. All mice elicited anti-peptide titres as determined by 
ELISA. However, although comparable titres were achieved in mice that had received identical peptide antigens, major differences in immunogenicity of particular peptides were observed. Antibody titres ranged from 1 : 200 to 1 : 102 000 (Table 1) . Polyclonal anti-peptide sera were subsequently probed for their reactivity with immunoblotted cellular PrP of sheep, which was purified on chelating Sepharose beads charged with copper ions (IMAC PrP C ). Six out of the 32 polyclonal antipeptide sera directed against peptides 3, 6, 10 and 15 reacted with two major antigen bands of molecular mass of 35-33 and 29-27 kDa, resembling the di-and monoglycosylated forms of PrP C (Table 1) . Interestingly, only one out of the two mice immunized with peptides 3 and 15, respectively, produced immunoblot-reactive antibodies, although peptide reactivity in ELISA was comparable.
Anti-peptide sera were further probed with immunoblotted pathological PrP (PrP Sc ) purified from scrapie sheep brain by detergent extraction and differential centrifugation. Sera were tested with proteinase K-treated and non-treated PrP Sc preparations. All six antisera (directed against peptides 3, 6, 10 and 15) which had reacted with ovine PrP C in immunoblot detected PrP Sc as well. The PrP-reactive antiserum directed against the amino-terminal region of the protein (according to peptide 3) did not react with proteinase K-treated PrP Sc , because this region is cleaved off after proteinase K treatment, leaving behind a resistant fragment of 27-30 kDa.
Generation of MAbs to PrP domains
In order to obtain MAbs with PrP specificity, we used splenocytes of those mice of which serum antibodies clearly detected PrP in immunoblot. Hybridomas were produced by fusion of splenocytes of mice 3b, 6a, 10a and 15a with the murine myeloma cell line SP2\0. Outgrowth of cells varied between 40-75 % among different fusions. Hybridoma cells which produced peptide-specific antibodies were selected by ELISA and cloned. In total, more than 2400 hybridomas were tested for antibody production, of which 47 were peptidespecific and were selected for further studies.
Detection of ovine PrP C in ELISA
Selected MAbs were probed for reactivity with nondenatured PrP C by ELISA, employing IMAC PrP C preparations and immunoaffinity-purified PrP C as antigens. IMAC PrP C was further purified on a protein A column charged with PrPspecific rabbit antibodies, in order to receive immunoaffinitypurified PrP C .
Two MAbs (p4 and r10) directed against the same aminoterminal region of PrP, according to peptide 6 (aa 89-104), reacted with IMAC PrP C in ELISA. Aside from these two MAbs, another four (a18, b7, l3 and l42) reacted with immunoaffinity-purified PrP C , but not with IMAC-purified PrP C in ELISA. These MAbs were directed to aa 145-163 (peptide 10). In contrast, fusions with mouse splenocytes Fig. 2 . Reactivity of MAbs with ovine PrP C and PrP Sc in immunoblot. MAbs directed against three different regions of the protein were tested for their reactivity with immunoblotted ovine PrP C (a) and PrP Sc (b). Immunoblot detection was competitively blocked by preabsorbing the antibodies with the corresponding peptide (indicated by ' j ' on top of the lanes ; ' k ' indicates non-treated MAb supernatants). PrP Sc was treated with proteinase K prior to electrophoretical separation. Lane C was developed with a polyclonal anti-peptide antibody from rabbit to ovine PrP (peptide 7). Fig. 3 . Cross-reactivity of MAb l3 with PrP C of different mammalian species. Immunoblotted PrP C of mouse, hamster, rat, rabbit, guinea-pig, mink, cat, dog, cattle, sheep, pig and man was probed with MAb l3 (directed against peptide 10). Antibody binding was visualized by subsequent incubation steps with alkaline phosphatase-conjugated antibodies to mouse IgG and with NBT/BCIP substrate. PrP C s were purified from brain tissue of the different species by IMAC. The immunoblot revealed a broad cross-reactivity of MAb l3 with PrP C of nine out of 12 of the species tested. PrP C of mouse, hamster and rat was not recognized. Note the higher molecular mass of bovine PrP C due to an additional octarepeat (six) compared to PrP of the other species (five octarepeats).
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producing antibodies to peptide 3 (aa 29-46) or peptide 15 (aa 209-228) did not yield PrP-reactive MAbs in ELISA (Table 2) .
MAb reactivity with PrP C of various species in immunoblot
Eight MAbs targeted against the three different regions of the protein, according to aa 89-104 (peptide 6), 145-163 (peptide 10) and 209-228 (peptide 15), reacted with ovine 
PrP C in immunoblot, five of which could be maintained as stably producing hybridomas (Fig. 2 a) . No PrP-specific MAb could be obtained directed to aa 29-46 (peptide 3). Interestingly some MAbs discriminated between denatured and non-denatured PrP C antigen as revealed by ELISA and immunoblot. MAbs e31 and e41 directed to aa 209-228 (peptide 15) bound to ovine PrP C only in immunoblot. In contrast, MAbs a18 and b7 directed to aa 145-163 (peptide 10) reacted only with immunoaffinity-purified PrP C in ELISA but with no other PrP C preparation, thus indicating conformational differences of PrP C (Table 2 ). To further demonstrate PrP specificity of those MAbs, supernatants were preincubated with the corresponding synthetic peptides prior to use in immunoblot. By this treatment banding reactions were completely inhibited (Fig. 2 a) . MAbs were eventually probed for binding denatured Fig. 4 . Immunoblot detection of bovine PrP Sc with MAb p4. MAb p4 (directed against peptide 6) was used in order to show its strong affinity to bovine PrP Sc . Brain stem of a non-infected cow was used as a negative control. The fibril purification procedure only used yields of aggregated fibrils consisting of pathological PrP but no cellular PrP. Extracts from equivalent amounts of each sample (2 g brain material) were loaded per lane. Accordingly, the negative control of healthy cow brain did not show any banding. In contrast, bovine PrP Sc is abundantly stained in either proteinase K-treated or non-treated extracts from both BSE-diseased animals. The designation ' j ' or 'k' on top of each lane indicates whether or not proteinase K was applied to the sample. cellular PrP of a variety of mammalian species including goat, cattle, man, pig, dog, cat, guinea-pig, rabbit, hamster and mouse (Fig. 3) . MAbs directed against peptide 10 and 15 showed a rather broad cross-reactivity with PrP C of cattle, goat, man, pig, dog, cat, mink and rabbit, while MAbs to peptide 6 reacted rather ruminant-specifically. Affinity of these MAbs to mouse and hamster PrP C was rather low (Table  3 a, b).
Reactivity of MAbs with pathological PrP of different species in immunoblot
MAbs were eventually probed for their ability to detect pathological PrP of sheep, goat, cattle, hamster and mouse in immunoblot. Pathological PrP, which is insoluble in detergent, was purified from tissue lysates by partitioning it from soluble and proteinase K-sensitive PrP C using differential ultracentrifugation. The efficacy of the proteinase K digestion step in terms of complete PrP C proteolysis and of the separation was continuously verified by extracting brain tissue samples from non-infected animals in control experiments (data not shown).
Ovine (Fig. 2 b) and bovine (Fig. 4) PrP Sc was detected remarkably strongly in immunoblot. In contrast, mouse and hamster PrP Sc was generally recognized only weakly, if at all, demonstrating substantial species preferences in respect to PrP detection. However, none of the MAbs was able to differentiate between either PrP isoform of any species probed in immunoblot (Table 3 a C using MAb l3 (directed against peptide 10) illustrates the sensitivity of the assay. Brain lysates equivalent to 3 mg (lane 1), 1n5 mg (2), 0n75 mg (3), 357 µg (4), 187n5 µg (5), 94 µg (6) and 47 µg (7) brain tissue were incubated with MAb l3 supernatants and immune complexes pelleted by protein A-Sepharose. Remaining proteins in the supernatant were concentrated by methanol precipitation. PrP C in these fractions was then analysed by SDS-PAGE and immunoblot again using MAb l3 as detection antibody. The majority of ovine PrP C was immunoprecipitated and pelleted as indicated by the stronger PrP-specific signals in lanes 2-7 in the pellet fractions. Crude lysate equivalent to 1n5 mg brain tissue was applied in lane C as a control. In order to demonstrate the specificity of the immunoprecipitation reaction a MAb raised to an epitope of pestiviruses was used as a negative control (lane 8). (b) Precipitation of bovine PrP C from crude brain homogenate (1 %) of cattle by different MAbs. MAbs p4 and r10 (directed against peptide 6) and l3 and l42 (directed against peptide 10) strongly precipitated bovine PrP C . A MAb directed against a pestivirus-specific epitope was used as a negative control (0).
MAb detection of native ruminant PrP C by immunoprecipitation
All MAbs which displayed PrP reactivity in either ELISA or immunoblot were used in immunoprecipitation experiments. Crude brain tissue homogenates from sheep (Fig. 5 a) , cattle (Fig. 5 b) , goat, man, rabbit, hamster and mouse were used. Four MAbs, p4, r10 (aa 89-104 ; peptide 6) and l3 and l42 (aa 145-163 ; peptide 15), precipitated authentic, non-denatured PrP C of ruminant species. MAbs l3 and l42 (aa 145-163) also recognized human PrP C and rabbit PrP C . In contrast, MAbs to peptide 15 (aa 209-228) did not precipitate non-denatured PrP C of any species (Table 3 c) .
The detection of ovine PrP C by immunoprecipitation is highly sensitive. Less than 200 µg sheep brain tissue was necessary to obtain clear PrP C precipitation bands (Fig. 5 a) .
However, attempts to immunoprecipitate non-denatured ovine and bovine PrP Sc were unsuccessful. It must be assumed that immunoprecipitation is hampered by the strong aggregating behaviour of pathological PrP which hinders accessibility of antibody binding sites.
Discussion
In the past the generation of MAbs to PrP has always been laborious and only few attempts have been successful. This is due to a substantial immunotolerance of mammals towards PrP when applied as a vaccine, because cellular PrP is expressed in all mammalian species and is highly conserved in its amino acid sequence. In order to achieve reasonable immune responses, mice had to be immunized with large amounts of PrP Sc which were obtained from brains of scrapie-diseased hamsters. In consequence, most existing MAbs were raised to hamster PrP and target three particular epitopes, all of which harbour major amino acid substitutions between murine and hamster PrP. Attempts to generate MAbs to other species like sheep, goat, cattle or man using purified PrP immunogens have, to our knowledge, not been described in the literature. The availability of MAbs specific for ovine and\or bovine PrP, however, would be useful for improving immunoassays for the diagnosis of sheep scrapie and BSE.
As an alternative approach in order to stimulate a PrPspecific immune response in mice and to generate MAbs specific for ruminant PrP, we immunized mice with 16 different synthetic peptides which were generated according to the fulllength amino acid sequence of ovine PrP.
Nearly all synthetic peptide vaccines induced excellent peptide-specific antibodies in mice. However, only mice immunized with the peptides corresponding to aa 29-46, 89-104, 145-163 and 209-228 developed antibodies which reacted with cellular and pathological ruminant PrP in immunoblot. Thus, high antibody titres in ELISA did not necessarily entail strong banding reactions with immunoblotted PrP. Moreover, immune responses to peptide antigens varied to a great extent among individual animals.
Mice that had developed the strongest PrP-reactive antisera in immunoblot were then utilized for the generation of MAbs. MAb-secreting hybridomas were selected by peptide ELISAs and MAbs were further characterized in respect to their immunoblot reactivity with cellular and pathological PrP purified from brain tissues of various species. Moreover, selected MAbs were probed with non-denatured PrP C of these species by immunoprecipitation and with different preparations of ovine PrP C by ELISA.
By this approach five different immunoblot-reactive MAbs were finally obtained directed against three different regions of ruminant [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] . However, none of these MAbs differentiated between the PrP isoforms under the strongly denaturing conditions applied in immunoblot, indicating that these MAbs primarily bind linear, nonconformation-specific epitopes (Fig. 5, Table 3 ). Most MAbs cross-reacted with immunoblotted PrP C of man, pig, dog, cat, mink and, to a lesser extent, with that of guinea-pig and rabbit. Little, if any, cross-reactivity was observed with immunoblotted hamster and mouse PrP C , due to existing immunotolerance effects in the vaccinated mice. In addition, comparably little cross-reactivity was obtained with immunoblotted pathological PrP of hamster and mouse.
MAbs l3 and l42 directed against aa 145-163 revealed a rather broad cross-reactivity with immunoblotted PrP C s of other species but no or weak interaction with that of mouse and hamster, whereas cross-reactivity of MAbs directed to aa 89-104 was rather restricted to ruminant PrP. The target region of MAbs to aa 89-104 includes the sites of frequent amino acid polymorphisms between mammalian species at aa 99 and aa 100. Reactivity of these MAbs is not diminished by proteinase K treatment of ovine and bovine PrP Sc . MAbs directed against aa 209-228 also demonstrated a broad interspecies reactivity. Interestingly, MAbs raised to given peptides did not always show the same binding patterns to immunoblotted PrP C s of different species. This indicates minor conformational differences in the paratopes of the MAbs stimulated to the same synthetic peptide immunogen, resulting in differences in their affinity and avidity.
We also obtained differences in the reactivity of MAbs with PrP C depending on the methods used for antigen preparation and the assay employed for antigen testing. We therefore conclude that PrP C prevails in unique conformations when probed by immunoprecipitation, ELISA or immunoblot. The least destructive assay and antigen extraction seems to be immunoprecipitation as PrP antigen is solubilized solely by mild detergent lysis of cells. Interestingly, MAbs to aa 89-104 and aa 145-163 but not to aa 209-228 immunoprecipitated ruminant PrP C , indicating that the latter region is less accessible for antibodies without denaturation. IMAC should also be a mild method for the preparation of PrP C antigen. Accordingly, aa 209-228 were still inaccessible for antibody binding. However, in contrast to the immunoprecipitation results, MAbs to aa 145-163 did not bind to IMAC PrP C in ELISA. It is feasible that PrP C prevails in di-or polymers in this preparation, which lacks detergent constituents, thus covering epitope aa 145-163. MAb binding was reconstituted by further immunoaffinity purification of IMAC PrP C using 3 M magnesium chloride solution as elution buffer. This treatment is indicative of a partial dissociation of PrP C aggregates, rendering epitope aa 145-163 fully accessible again. Immunoblotted PrP C constitutes a highly denatured linearized antigen in which all three regions of PrP are accessible for antibodies.
Taken together, we were able to generate MAbs to both isoforms of ruminant PrP that differ in their target sequences from the three epitopes which have been described for PrP of hamster and man in the past. MAbs can be used in immunoprecipitation assays, ELISA and\or immunoblot and exhibit cross-reactivity with cellular and pathological PrP of a variety of other mammalian species. Therefore these MAbs can be excellent tools for the immunochemical diagnosis of BSE and scrapie as well as for pathogenesis studies on these diseases.
Note added in proof. Korth et al. (Nature 390, 74-77, 1997) reported recently on the generation of a PrP Sc -specific MAb which was raised by immunization of PrP-ablated mice with recombinant bovine PrP C . This MAb is directed to a non-linear epitope composed of amino acids 145-153, 165-173 and 207-229 (calculation according to Fig. 1 ).
